NEW YORK – Global stocks were mixed Wednesday as markets digested solid US economic data and positive clinical research on the Oxford-AstraZeneca coronavirus vaccine.
Both the Dow and S&P 500 edged higher after data showed stronger-than-expected private sector hiring in January and accelerating growth in the US services sector.
Analysts also cited clinical data showing the Oxford-AstraZeneca Covid-19 vaccine reduces virus transmission and is highly protective after a single dose.
The market appears to have stabilized following last week’s volatility, which was brought on by a social media-driven surge in shares of GameStop, AMC Entertainment and other…
Keep on reading: Global stocks steady on solid US data, positive vaccine news